| 1 | Long qt syndrome 1 | Enrichment | CAV3, KCNH2, KCNQ1, NOS1AP, SCN4B, SCN5A, SNTA1 | 7.36 |
| 2 | Long qt syndrome | Enrichment | CAV3, KCNH2, KCNQ1, RYR2, SCN5A, SNTA1 | 5.87 |
| 3 | Long qt syndrome 2 | Enrichment | KCNH2, KCNQ1, SCN5A | 5.20 |
| 4 | Atrial fibrillation | Enrichment | KCNQ1, SCN5A, SNTA1 | 5.20 |
| 5 | Haddad syndrome | Enrichment | ASCL1, PHOX2B, RET | 5.20 |
| 6 | Brugada syndrome | Enrichment | GPD1L, KCNH2, KCNJ8, SCN3B, SCN5A | 4.95 |
| 7 | Sudden infant death syndrome | Enrichment | CAV3, KCNJ8, KCNQ1, SCN5A | 4.42 |
| 8 | Systemic lupus erythematosus | Enrichment | C4A, C4B, IL10, MECP2, TNF | 4.06 |
| 9 | Congenital central hypoventilation syndrome | Enrichment | BDNF, PHOX2B, RET | 3.90 |
| 10 | Obsessive-compulsive disorder | Enrichment | HTR2A, SLC6A4 | 3.86 |
| 11 | B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3) | Enrichment | PBX1, TCF3 | 3.86 |
| 12 | Familial atrial fibrillation | Enrichment | KCNQ1, SCN3B, SCN4B, SCN5A | 3.79 |
| 13 | Congenital long qt syndrome | Enrichment | KCNH2, KCNQ1, SCN5A | 3.49 |
| 14 | Thyroid carcinoma, familial medullary | Enrichment | ESR2, RET | 3.39 |
| 15 | Epilepsy, nocturnal frontal lobe, 1 | Enrichment | CHRNA4, CHRNB2 | 3.39 |
| 16 | Mitochondrial trifunctional protein deficiency 1 | Enrichment | HADHA, HADHB | 3.39 |
| 17 | Mitochondrial trifunctional protein deficiency | Enrichment | HADHA, HADHB | 3.39 |
| 18 | Ventricular fibrillation, paroxysmal familial, 1 | Enrichment | RYR2, SCN5A | 3.09 |
| 19 | Central hypoventilation syndrome, congenital, 1 | Enrichment | PHOX2B, RET | 3.09 |
| 20 | Autosomal dominant nocturnal frontal lobe epilepsy | Enrichment | CHRNA4, CHRNB2 | 3.09 |
| 21 | Sick sinus syndrome | Enrichment | MECP2, SCN5A | 3.09 |
| 22 | Paroxysmal familial ventricular fibrillation | Enrichment | RYR2, SCN5A | 3.09 |
| 23 | Major depressive disorder | Enrichment | HTR2A, TPH2 | 2.87 |
| 24 | Heart conduction disease | Enrichment | RYR2, SCN5A | 2.87 |
| 25 | Congenital short qt syndrome | Enrichment | KCNH2, KCNQ1 | 2.87 |
| 26 | Rubinstein-taybi syndrome 1 | Enrichment | CREBBP, EP300 | 2.70 |
| 27 | Chromosome 16p13.3 deletion syndrome, proximal | Enrichment | CREBBP, EP300 | 2.70 |
| 28 | Adrenocortical carcinoma | Enrichment | CTNNB1, PRKAR1A | 2.70 |
| 29 | Brugada syndrome 1 | Enrichment | KCNH2, SCN5A | 2.56 |
| 30 | Common variable immunodeficiency | Enrichment | NFKB1, NFKB2 | 2.56 |
| 31 | Focal epilepsy | Enrichment | MECP2, SNAP25 | 2.56 |
| 32 | Autosomal dominant sleep-related hypermotor epilepsy | Enrichment | CHRNA4, CHRNB2 | 2.56 |
| 33 | Alternating hemiplegia of childhood | Enrichment | ATP1A3, SLC1A3 | 2.44 |
| 34 | Immunodeficiency due to a classical component pathway complement deficiency | Enrichment | C4A, C4B | 2.44 |
| 35 | Hirschsprung disease 1 | Enrichment | ECE1, PHOX2B, RET | 2.34 |
| 36 | Ellis-van creveld syndrome | Enrichment | PRKACA, PRKACB | 2.33 |
| 37 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | CHRNA4, CHRNB4, MEF2C, PPARGC1A | 2.33 |
| 38 | Asthma | Enrichment | IL13, TNF | 2.15 |
| 39 | Frontotemporal dementia 1 | Enrichment | CHRNA4, CHRNB4 | 2.15 |
| 40 | Presynaptic congenital myasthenic syndromes | Enrichment | CHAT, SNAP25 | 2.15 |
| 41 | Dystonia | Enrichment | ATP1A3, MECP2, TH | 2.10 |
| 42 | Cardiac conduction defect | Enrichment | RYR2, SCN5A | 2.08 |
| 43 | Stereotypic movement disorder | Enrichment | MECP2, SNAP25 | 2.01 |
| 44 | Autism | Enrichment | CC2D1A, CREBBP, DEAF1, MECP2 | 2.00 |
| 45 | Epilepsy | Enrichment | ATP1A3, GABRA1, MECP2 | 1.94 |
| 46 | Palmoplantar keratoderma and congenital alopecia 1 | Enrichment | GJA1 | 1.93 |
| 47 | Multiple endocrine neoplasia, type iib | Enrichment | RET | 1.93 |
| 48 | Diabetes insipidus, neurohypophyseal | Enrichment | AVP | 1.93 |
| 49 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 1.93 |
| 50 | Apnea, central sleep | Enrichment | CHAT | 1.93 |
| 51 | Focal segmental glomerulosclerosis 10 | Enrichment | LMX1B | 1.93 |
| 52 | Hypoplastic left heart syndrome 1 | Enrichment | GJA1 | 1.93 |
| 53 | Prostate cancer, hereditary, x-linked 3 | Enrichment | AR | 1.93 |
| 54 | Androgen insensitivity, partial | Enrichment | AR | 1.93 |
| 55 | Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss | Enrichment | ATP1A3 | 1.93 |
| 56 | Facial hypertrichosis | Enrichment | MECP2 | 1.93 |
| 57 | Carney complex, type 1 | Enrichment | PRKAR1A | 1.93 |
| 58 | Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2 | Enrichment | SLC25A4 | 1.93 |
| 59 | Oculodentodigital dysplasia | Enrichment | GJA1 | 1.93 |
| 60 | Episodic ataxia, type 6 | Enrichment | SLC1A3 | 1.93 |
| 61 | Maturity-onset diabetes of the young, type 6 | Enrichment | NEUROD1 | 1.93 |
| 62 | Maturity-onset diabetes of the young, type 2 | Enrichment | GCK | 1.93 |
| 63 | Epilepsy, idiopathic generalized 13 | Enrichment | GABRA1 | 1.93 |
| 64 | Nail-patella syndrome | Enrichment | LMX1B | 1.93 |
| 65 | Long qt syndrome 10 | Enrichment | SCN4B | 1.93 |
| 66 | Glucocorticoid resistance, generalized | Enrichment | NR3C1 | 1.93 |
| 67 | Short qt syndrome 1 | Enrichment | KCNH2 | 1.93 |
| 68 | Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis | Enrichment | IL1RN | 1.93 |
| 69 | Wilms tumor 6 | Enrichment | REST | 1.93 |
| 70 | Alternating hemiplegia of childhood 2 | Enrichment | ATP1A3 | 1.93 |
| 71 | Acyl-coa dehydrogenase, medium-chain, deficiency of | Enrichment | ACADM | 1.93 |
| 72 | Atransferrinemia | Enrichment | TF | 1.93 |
| 73 | Craniometaphyseal dysplasia, autosomal recessive | Enrichment | GJA1 | 1.93 |
| 74 | Mitochondrial dna depletion syndrome 12b , autosomal recessive | Enrichment | SLC25A4 | 1.93 |
| 75 | Ciliary dyskinesia, primary, 47, and lissencephaly | Enrichment | TP73 | 1.93 |
| 76 | Endove syndrome, limb-brain type | Enrichment | EN1 | 1.93 |
| 77 | Intellectual developmental disorder, x-linked, syndromic, lubs type | Enrichment | MECP2 | 1.93 |
| 78 | Developmental and epileptic encephalopathy 117 | Enrichment | SNAP25 | 1.93 |
| 79 | Developmental and epileptic encephalopathy 58 | Enrichment | NTRK2 | 1.93 |
| 80 | Developmental and epileptic encephalopathy 99 | Enrichment | ATP1A3 | 1.93 |
| 81 | Agammaglobulinemia 8b, autosomal recessive | Enrichment | TCF3 | 1.93 |
| 82 | Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | Enrichment | PBX1 | 1.93 |
| 83 | Auriculocondylar syndrome 4 | Enrichment | HDAC9 | 1.93 |
| 84 | Autism x-linked 3 | Enrichment | MECP2 | 1.93 |
| 85 | Nephrotic syndrome, type 22 | Enrichment | NOS1AP | 1.93 |
| 86 | Lymphedema, primary, with myelodysplasia | Enrichment | GATA2 | 1.93 |
| 87 | Complement component 4a deficiency | Enrichment | C4A | 1.93 |
| 88 | Graft-versus-host disease | Enrichment | IL10 | 1.93 |
| 89 | Brunner syndrome | Enrichment | MAOA | 1.93 |
| 90 | Cardioacrofacial dysplasia 2 | Enrichment | PRKACB | 1.93 |
| 91 | Brugada syndrome 2 | Enrichment | GPD1L | 1.93 |
| 92 | Developmental delay, impaired speech, and behavioral abnormalities | Enrichment | SPTBN1 | 1.93 |
| 93 | Central diabetes insipidus | Enrichment | AVP | 1.93 |
| 94 | Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | Enrichment | MEF2C | 1.93 |
| 95 | Myxoma, intracardiac | Enrichment | PRKAR1A | 1.93 |
| 96 | Oculodentodigital dysplasia, autosomal recessive | Enrichment | GJA1 | 1.93 |
| 97 | Mitochondrial dna depletion syndrome 12a , autosomal dominant | Enrichment | SLC25A4 | 1.93 |
| 98 | Allergic rhinitis | Enrichment | IL13 | 1.93 |
| 99 | Hyperinsulinemic hypoglycemia, familial, 3 | Enrichment | GCK | 1.93 |
| 100 | Developmental and epileptic encephalopathy 19 | Enrichment | GABRA1 | 1.93 |
| 101 | Microvascular complications of diabetes 1 | Enrichment | VEGFA | 1.93 |
| 102 | Agammaglobulinemia 8a, autosomal dominant | Enrichment | TCF3 | 1.93 |
| 103 | Epilepsy, nocturnal frontal lobe, 3 | Enrichment | CHRNB2 | 1.93 |
| 104 | Fibrosis of extraocular muscles, congenital, 2 | Enrichment | PHOX2A | 1.93 |
| 105 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | Enrichment | GRIN1 | 1.93 |
| 106 | Microvascular complications of diabetes 4 | Enrichment | IL1RN | 1.93 |
| 107 | Ovarian dysgenesis 8 | Enrichment | ESR2 | 1.93 |
| 108 | Spastic paraplegia 13, autosomal dominant | Enrichment | HSPD1 | 1.93 |
| 109 | Hirschsprung disease, cardiac defects, and autonomic dysfunction | Enrichment | ECE1 | 1.93 |
| 110 | Deafness, autosomal dominant 27 | Enrichment | REST | 1.93 |
| 111 | Periodic fever, menstrual cycle-dependent | Enrichment | HTR1A | 1.93 |
| 112 | Long qt syndrome 12 | Enrichment | SNTA1 | 1.93 |
| 113 | Interleukin 6, serum level of, quantitative trait locus | Enrichment | IL6R | 1.93 |
| 114 | Immunodeficiency 21 | Enrichment | GATA2 | 1.93 |
| 115 | Blood group, chido/rodgers system | Enrichment | C4A | 1.93 |
| 116 | Complement component 4b deficiency | Enrichment | C4B | 1.93 |
| 117 | Soluble interleukin-6 receptor, serum level of, quantitative trait locus | Enrichment | IL6R | 1.93 |
| 118 | Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements | Enrichment | VAMP2 | 1.93 |
| 119 | Hyper-ige syndrome 5, autosomal recessive, with recurrent infections | Enrichment | IL6R | 1.93 |
| 120 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 1.93 |
| 121 | Epilepsy with generalized tonic-clonic seizures | Enrichment | SNAP25 | 1.93 |
| 122 | Syndromic x-linked intellectual disability lubs type | Enrichment | MECP2 | 1.93 |
| 123 | Brugada syndrome 7 | Enrichment | SCN3B | 1.93 |
| 124 | Developmental and epileptic encephalopathy 101 | Enrichment | GRIN1 | 1.93 |
| 125 | Mitochondrial metabolism disease | Enrichment | SLC25A4 | 1.93 |
| 126 | Obesity, hyperphagia, and developmental delay | Enrichment | NTRK2 | 1.93 |
| 127 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant | Enrichment | GRIN1 | 1.93 |
| 128 | Schizophrenia 16 | Enrichment | VIPR2 | 1.93 |
| 129 | Fibromatosis, gingival, 5 | Enrichment | REST | 1.93 |
| 130 | Developmental and epileptic encephalopathy 56 | Enrichment | YWHAG | 1.93 |
| 131 | Ctcf-related disorder | Enrichment | CTCF | 1.93 |
| 132 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 1.93 |
| 133 | Erythrokeratodermia variabilis et progressiva 3 | Enrichment | GJA1 | 1.93 |
| 134 | Deafness-lymphedema-leukemia syndrome | Enrichment | GATA2 | 1.93 |
| 135 | Deficiency in anterior pituitary function - variable immunodeficiency syndrome | Enrichment | NFKB2 | 1.93 |
| 136 | Mitochondrial trifunctional protein deficiency 2 | Enrichment | HADHB | 1.93 |
| 137 | Lipoid nephrosis | Enrichment | LMX1B | 1.93 |
| 138 | Menke-hennekam syndrome 1 | Enrichment | CREBBP | 1.93 |
| 139 | Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting | Enrichment | AQP4 | 1.93 |
| 140 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.93 |
| 141 | Acute fatty liver of pregnancy | Enrichment | HADHA | 1.93 |
| 142 | Aspiration pneumonia | Enrichment | CHAT | 1.93 |
| 143 | Rubinstein-taybi syndrome due to 16p13.3 microdeletion | Enrichment | CREBBP | 1.93 |
| 144 | Gestational diabetes | Enrichment | GCK | 1.93 |
| 145 | Atp1a3-related disorder | Enrichment | ATP1A3 | 1.93 |
| 146 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 1.93 |
| 147 | Oculogyric crisis | Enrichment | ATP1A3 | 1.93 |
| 148 | 5q14.3 microdeletion syndrome | Enrichment | MEF2C | 1.93 |
| 149 | Thyroid cancer | Enrichment | RET | 1.93 |
| 150 | Complete atrioventricular septal defect without ventricular hypoplasia | Enrichment | MEF2C | 1.93 |
| 151 | Hemiplegia | Enrichment | ATP1A3 | 1.93 |
| 152 | Complete androgen insensitivity syndrome | Enrichment | AR | 1.93 |
| 153 | Medium-chain acyl-coenzyme a dehydrogenase deficiency | Enrichment | ACADM | 1.93 |
| 154 | Menke-hennekam syndrome | Enrichment | CREBBP | 1.93 |
| 155 | Hirschsprung disease-ganglioneuroblastoma syndrome | Enrichment | PHOX2B | 1.93 |
| 156 | Intellectual disability, autosomal dominant 8 | Enrichment | GRIN1 | 1.93 |
| 157 | Hypomyelination of early myelinating structures | Enrichment | PLP1 | 1.93 |
| 158 | Severe primary trimethylaminuria | Enrichment | FMO3 | 1.93 |
| 159 | Mef2c-related disorder | Enrichment | MEF2C | 1.93 |
| 160 | Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | Enrichment | PAH | 1.93 |
| 161 | Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | Enrichment | THRB | 1.93 |
| 162 | Distal 17p13.3 microdeletion syndrome | Enrichment | YWHAE | 1.93 |
| 163 | Generalized resistance to thyroid hormone | Enrichment | THRB | 1.93 |
| 164 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.93 |
| 165 | Gastrointestinal system disease | Enrichment | RET | 1.93 |
| 166 | Hereditary arginine vasopressin deficiency | Enrichment | AVP | 1.93 |
| 167 | Multiple endocrine neoplasia | Enrichment | RET | 1.93 |
| 168 | Rare genetic intellectual disability | Enrichment | CREBBP, EP300 | 1.89 |
| 169 | Type 2 diabetes mellitus | Enrichment | GCK, IL6, NEUROD1 | 1.89 |
| 170 | Wolff-parkinson-white syndrome | Enrichment | KCNQ1, SCN5A | 1.83 |
| 171 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | RYR2, SCN5A | 1.83 |
| 172 | Microcephaly | Enrichment | CTNNB1, EP300, MECP2, SNAP25, YWHAG | 1.83 |
| 173 | Hypertension, essential | Enrichment | ECE1, GNB3 | 1.78 |
| 174 | Behcet syndrome | Enrichment | C4A, IL10 | 1.69 |
| 175 | Autosomal dominant non-syndromic intellectual disability | Enrichment | DEAF1, GRIN1, YWHAZ | 1.68 |
| 176 | Maturity-onset diabetes of the young | Enrichment | GCK, NEUROD1 | 1.65 |
| 177 | Seizures, benign familial neonatal, 1 | Enrichment | ATP1A3 | 1.63 |
| 178 | Thyroid hormone resistance, selective pituitary | Enrichment | THRB | 1.63 |
| 179 | Atrial standstill 1 | Enrichment | SCN5A | 1.63 |
| 180 | Progressive familial heart block, type ia | Enrichment | SCN5A | 1.63 |
| 181 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome | Enrichment | GATA3 | 1.63 |
| 182 | Maturity-onset diabetes of the young, type 1 | Enrichment | GCK | 1.63 |
| 183 | Fibromatosis, gingival, 1 | Enrichment | REST | 1.63 |
| 184 | Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | Enrichment | RYR2 | 1.63 |
| 185 | Major affective disorder 1 | Enrichment | TPH2 | 1.63 |
| 186 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 1.63 |
| 187 | Galactosemia ii | Enrichment | NR3C1 | 1.63 |
| 188 | Thyroid hormone resistance, generalized, autosomal dominant | Enrichment | THRB | 1.63 |
| 189 | Thumb deformity | Enrichment | CREBBP | 1.63 |
| 190 | Spinal and bulbar muscular atrophy, x-linked 1 | Enrichment | AR | 1.63 |
| 191 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.63 |
| 192 | Encephalopathy, neonatal severe, due to mecp2 mutations | Enrichment | MECP2 | 1.63 |
| 193 | Thyroid hormone resistance, generalized, autosomal recessive | Enrichment | THRB | 1.63 |
| 194 | Leukodystrophy, hypomyelinating, 4 | Enrichment | HSPD1 | 1.63 |
| 195 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 1.63 |
| 196 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | PRKAR1A | 1.63 |
| 197 | Sick sinus syndrome 1 | Enrichment | SCN5A | 1.63 |
| 198 | Segawa syndrome, autosomal recessive | Enrichment | TH | 1.63 |
| 199 | Diabetes mellitus, permanent neonatal, 1 | Enrichment | GCK | 1.63 |
| 200 | Bone marrow failure syndrome 2 | Enrichment | GCK | 1.63 |
| 201 | Hallermann-streiff syndrome | Enrichment | GJA1 | 1.63 |
| 202 | Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities | Enrichment | PAH | 1.63 |
| 203 | Carnitine palmitoyltransferase i deficiency | Enrichment | CPT1A | 1.63 |
| 204 | Atrial fibrillation, familial, 10 | Enrichment | SCN5A | 1.63 |
| 205 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 1.63 |
| 206 | Aromatic l-amino acid decarboxylase deficiency | Enrichment | DDC | 1.63 |
| 207 | Immunodeficiency, common variable, 12, with autoimmunity | Enrichment | NFKB1 | 1.63 |
| 208 | Immunodeficiency, common variable, 10 | Enrichment | NFKB2 | 1.63 |
| 209 | Syndactyly, type iii | Enrichment | GJA1 | 1.63 |
| 210 | Syndactyly, type v | Enrichment | GJA1 | 1.63 |
| 211 | Diarrhea 8, secretory sodium, congenital | Enrichment | SLC9A3 | 1.63 |
| 212 | Long qt syndrome 3 | Enrichment | SCN5A | 1.63 |
| 213 | Sinoatrial node disease | Enrichment | SCN5A | 1.63 |
| 214 | Trimethylaminuria | Enrichment | FMO3 | 1.63 |
| 215 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 1.63 |
| 216 | 46,xy sex reversal 1 | Enrichment | AR | 1.63 |
| 217 | Microcephaly 21, primary, autosomal recessive | Enrichment | GAPDH | 1.63 |
| 218 | Androgen insensitivity syndrome | Enrichment | AR | 1.63 |
| 219 | Menke-hennekam syndrome 2 | Enrichment | EP300 | 1.63 |
| 220 | Usher syndrome, type iv | Enrichment | PRKAR1A | 1.63 |
| 221 | Intellectual developmental disorder, x-linked, syndromic 13 | Enrichment | MECP2 | 1.63 |
| 222 | Thyroid hormone resistance syndrome | Enrichment | THRB | 1.63 |
| 223 | Hypospadias 1, x-linked | Enrichment | AR | 1.63 |
| 224 | Immunodeficiency 127 | Enrichment | TNF | 1.63 |
| 225 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.63 |
| 226 | Craniometaphyseal dysplasia | Enrichment | GJA1 | 1.63 |
| 227 | Bilateral generalized polymicrogyria | Enrichment | GRIN1 | 1.63 |
| 228 | Intellectual developmental disorder, autosomal dominant 21 | Enrichment | CTCF | 1.63 |
| 229 | Glycogen storage disease xii | Enrichment | ALDOA | 1.63 |
| 230 | Ventricular tachycardia, catecholaminergic polymorphic, 2 | Enrichment | RYR2 | 1.63 |
| 231 | Acute basophilic leukemia | Enrichment | MYB | 1.63 |
| 232 | Acute myeloid leukemia with kat6a-crebbp fusion | Enrichment | CREBBP | 1.63 |
| 233 | X-linked intellectual disability-psychosis-macroorchidism syndrome | Enrichment | MECP2 | 1.63 |
| 234 | Cardiovascular system disease | Enrichment | KCNQ1 | 1.63 |
| 235 | Vulto-van silfhout-de vries syndrome | Enrichment | DEAF1 | 1.63 |
| 236 | Acrodysostosis | Enrichment | PRKAR1A | 1.63 |
| 237 | Chromosome 15q13.3 deletion syndrome | Enrichment | CHRNA7 | 1.63 |
| 238 | Medullary thyroid carcinoma | Enrichment | RET | 1.63 |
| 239 | Intellectual developmental disorder, autosomal recessive 3 | Enrichment | CC2D1A | 1.63 |
| 240 | Fibrolamellar carcinoma | Enrichment | PRKACA | 1.63 |
| 241 | Angiocentric glioma | Enrichment | MYB | 1.63 |
| 242 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 1.63 |
| 243 | B-lymphoblastic leukemia/lymphoma with hyperdiploidy | Enrichment | GATA3 | 1.63 |
| 244 | Hypoparathyroidism-deafness-renal disease syndrome | Enrichment | GATA3 | 1.63 |
| 245 | Intellectual developmental disorder with or without epilepsy or cerebellar ataxia | Enrichment | RORA | 1.63 |
| 246 | Primary trimethylaminuria | Enrichment | FMO3 | 1.63 |
| 247 | 9q33.3q34.11 microdeletion syndrome | Enrichment | LMX1B | 1.63 |
| 248 | Myasthenic syndrome, congenital, 21, presynaptic | Enrichment | CHAT | 1.63 |
| 249 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.63 |
| 250 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 1.63 |
| 251 | Autosomal dominant nonsyndromic deafness | Enrichment | GATA3 | 1.63 |
| 252 | Posterior hypospadias | Enrichment | AR | 1.63 |
| 253 | Jervell-lange nielsen syndrome | Enrichment | KCNQ1 | 1.63 |
| 254 | Isolated atrial standstill | Enrichment | SCN5A | 1.63 |
| 255 | Qualitative or quantitative defects of caveolin-3 | Enrichment | CAV3 | 1.63 |
| 256 | Teratoma | Enrichment | CTNNB1 | 1.63 |
| 257 | Renal hypoplasia, bilateral | Enrichment | PBX1 | 1.63 |
| 258 | B-lymphoblastic leukemia/lymphoma with t(17;19) | Enrichment | TCF3 | 1.63 |
| 259 | Common variable immunodeficiency 12 | Enrichment | NFKB1 | 1.63 |
| 260 | Progressive bulbar palsy | Enrichment | MECP2 | 1.63 |
| 261 | Bruxism | Enrichment | MECP2 | 1.63 |
| 262 | Hepatocellular carcinoma | Enrichment | CTNNB1, RET | 1.57 |
| 263 | Undetermined early-onset epileptic encephalopathy | Enrichment | ATP1A3, NTRK2, YWHAG | 1.56 |
| 264 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | MYB, TLX3 | 1.53 |
| 265 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.46 |
| 266 | Laryngomalacia | Enrichment | MECP2 | 1.46 |
| 267 | Dystonia 12 | Enrichment | ATP1A3 | 1.46 |
| 268 | Dystonia, dopa-responsive | Enrichment | TH | 1.46 |
| 269 | Nijmegen breakage syndrome | Enrichment | GCK | 1.46 |
| 270 | Cantu syndrome | Enrichment | KCNJ8 | 1.46 |
| 271 | Sengers syndrome | Enrichment | SLC25A4 | 1.46 |
| 272 | Myasthenic syndrome, congenital, 6, presynaptic | Enrichment | CHAT | 1.46 |
| 273 | Pelizaeus-merzbacher disease | Enrichment | PLP1 | 1.46 |
| 274 | Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies | Enrichment | SLC9A3 | 1.46 |
| 275 | Pituitary hormone deficiency, combined, 2 | Enrichment | PAH | 1.46 |
| 276 | Spastic paraplegia 2, x-linked | Enrichment | PLP1 | 1.46 |
| 277 | Rippling muscle disease 2 | Enrichment | CAV3 | 1.46 |
| 278 | Sudden infant death with dysgenesis of the testes syndrome | Enrichment | TSPYL1 | 1.46 |
| 279 | Psoriatic arthritis | Enrichment | TNF | 1.46 |
| 280 | Atrial fibrillation, familial, 3 | Enrichment | KCNQ1 | 1.46 |
| 281 | Long qt syndrome 9 | Enrichment | CAV3 | 1.46 |
| 282 | Long-chain 3-hydroxyacyl-coa dehydrogenase deficiency | Enrichment | HADHA | 1.46 |
| 283 | Short qt syndrome 2 | Enrichment | KCNQ1 | 1.46 |
| 284 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.46 |
| 285 | Myopathy, distal, tateyama type | Enrichment | CAV3 | 1.46 |
| 286 | Miller-dieker lissencephaly syndrome | Enrichment | YWHAE | 1.46 |
| 287 | Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy | Enrichment | SPTBN1 | 1.46 |
| 288 | Neuroblastoma 2 | Enrichment | PHOX2B | 1.46 |
| 289 | Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation | Enrichment | KCNH2 | 1.46 |
| 290 | Chromosome 17p13.3, centromeric, duplication syndrome | Enrichment | YWHAE | 1.46 |
| 291 | Anus, imperforate | Enrichment | CTNNB1 | 1.46 |
| 292 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.46 |
| 293 | Tethered spinal cord syndrome | Enrichment | CREBBP | 1.46 |
| 294 | Bronchopulmonary dysplasia | Enrichment | CHAT | 1.46 |
| 295 | Desmoid tumor | Enrichment | CTNNB1 | 1.46 |
| 296 | Neurodevelopmental disorder with hypotonia and impaired expressive language and with or without seizures | Enrichment | DEAF1 | 1.46 |
| 297 | Gingival overgrowth | Enrichment | RET | 1.46 |
| 298 | Intraocular pressure quantitative trait locus | Enrichment | CREBBP | 1.46 |
| 299 | Migraine without aura | Enrichment | TNF | 1.46 |
| 300 | End stage renal disease | Enrichment | GATA3 | 1.46 |
| 301 | Desmoplastic/nodular medulloblastoma | Enrichment | CTCF | 1.46 |
| 302 | Adenoid cystic carcinoma | Enrichment | MYB | 1.46 |
| 303 | Respiratory failure | Enrichment | TP73 | 1.46 |
| 304 | Pelizeaus-merzbacher spectrum disorder | Enrichment | PLP1 | 1.46 |
| 305 | Melanoma of soft tissue | Enrichment | CREB1 | 1.46 |
| 306 | Enchondromatosis | Enrichment | HIF1A | 1.46 |
| 307 | Rasopathy | Enrichment | DDC, PAH | 1.43 |
| 308 | Autism spectrum disorder | Enrichment | DEAF1, MECP2, MEF2C, PBX1 | 1.41 |
| 309 | Kaposi sarcoma | Enrichment | IL6 | 1.34 |
| 310 | Jervell and lange-nielsen syndrome 1 | Enrichment | KCNQ1 | 1.34 |
| 311 | Small cell cancer of the lung | Enrichment | TP73 | 1.34 |
| 312 | Glycogen storage disease ia | Enrichment | G6PC1 | 1.34 |
| 313 | Phenylketonuria | Enrichment | PAH | 1.34 |
| 314 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 1.34 |
| 315 | Developmental and epileptic encephalopathy 2 | Enrichment | SNAP25 | 1.34 |
| 316 | Propionic acidemia | Enrichment | PAH | 1.34 |
| 317 | Maturity-onset diabetes of the young, type 3 | Enrichment | GCK | 1.34 |
| 318 | Developmental and epileptic encephalopathy 4 | Enrichment | LMX1B | 1.34 |
| 319 | Immunodeficiency, common variable, 1 | Enrichment | NFKB2 | 1.34 |
| 320 | Pilomatrixoma | Enrichment | CTNNB1 | 1.34 |
| 321 | Carney complex variant | Enrichment | PRKAR1A | 1.34 |
| 322 | Ciliary dyskinesia, primary, 7 | Enrichment | CDCA7L | 1.34 |
| 323 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.34 |
| 324 | Cardiomyopathy, familial hypertrophic, 26 | Enrichment | KCNH2 | 1.34 |
| 325 | Tobacco addiction | Enrichment | CHRNA4 | 1.34 |
| 326 | Alazami syndrome | Enrichment | CTNNB1 | 1.34 |
| 327 | Craniopharyngioma | Enrichment | CTNNB1 | 1.34 |
| 328 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | YWHAZ | 1.34 |
| 329 | Pregnancy loss, recurrent 1 | Enrichment | KCNQ1 | 1.34 |
| 330 | Hydrocephalus, congenital, 2, with or without brain or eye anomalies | Enrichment | ACADM | 1.34 |
| 331 | Diabetes insipidus | Enrichment | AVP | 1.34 |
| 332 | Hereditary progressive cardiac conduction defect | Enrichment | SCN5A | 1.34 |
| 333 | Cerebral malaria | Enrichment | TNF | 1.34 |
| 334 | Systemic-onset juvenile idiopathic arthritis | Enrichment | IL6 | 1.34 |
| 335 | Gingival fibromatosis | Enrichment | REST | 1.34 |
| 336 | Familial sick sinus syndrome | Enrichment | SCN5A | 1.34 |
| 337 | Familial hypertrophic cardiomyopathy | Enrichment | CAV3, KCNH2 | 1.24 |
| 338 | Enchondromatosis, multiple, ollier type | Enrichment | HIF1A | 1.24 |
| 339 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.24 |
| 340 | Smith-magenis syndrome | Enrichment | DEAF1 | 1.24 |
| 341 | Multiple endocrine neoplasia, type iia | Enrichment | RET | 1.24 |
| 342 | Rheumatoid arthritis, systemic juvenile | Enrichment | IL6 | 1.24 |
| 343 | Rubinstein-taybi syndrome 2 | Enrichment | EP300 | 1.24 |
| 344 | Systemic lupus erythematosus 16 | Enrichment | C4A | 1.24 |
| 345 | Pervasive developmental disorder | Enrichment | SPTBN1 | 1.24 |
| 346 | Cardiac arrest | Enrichment | SCN5A | 1.24 |
| 347 | Hypoglycemia | Enrichment | G6PC1 | 1.24 |
| 348 | Vascular dementia | Enrichment | TNF | 1.24 |
| 349 | Cleft upper lip | Enrichment | GJA1 | 1.24 |
| 350 | Endometrial stromal sarcoma | Enrichment | YWHAE | 1.24 |
| 351 | Rare pervasive developmental disorder | Enrichment | SPTBN1 | 1.24 |
| 352 | Breast cancer | Enrichment | JUN, PAH, RET | 1.24 |
| 353 | Left ventricular noncompaction | Enrichment | RYR2, SCN5A | 1.20 |
| 354 | Angelman syndrome | Enrichment | MECP2 | 1.17 |
| 355 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.17 |
| 356 | Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 | Enrichment | SLC25A4 | 1.17 |
| 357 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | GCK | 1.17 |
| 358 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | BDNF | 1.17 |
| 359 | Hyperphenylalaninemia, bh4-deficient, a | Enrichment | PAH | 1.17 |
| 360 | Type 1 diabetes mellitus | Enrichment | IL6 | 1.17 |
| 361 | Anxiety | Enrichment | SLC6A4 | 1.17 |
| 362 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | RYR2 | 1.17 |
| 363 | Autosomal recessive intellectual developmental disorder | Enrichment | CC2D1A | 1.17 |
| 364 | Congenital fibrosis of the extraocular muscles | Enrichment | PHOX2A | 1.17 |
| 365 | Il10-related early-onset inflammatory bowel disease | Enrichment | IL10 | 1.17 |
| 366 | Hypertrichosis | Enrichment | CREBBP | 1.17 |
| 367 | Kidney clear cell sarcoma | Enrichment | YWHAE | 1.17 |
| 368 | Nonsyndromic genetic hyperinsulinism | Enrichment | GCK | 1.17 |
| 369 | Childhood absence epilepsy | Enrichment | GABRA1 | 1.17 |
| 370 | Sporadic pheochromocytoma/secreting paraganglioma | Enrichment | RET | 1.17 |
| 371 | Silver-russell syndrome 1 | Enrichment | KCNQ1 | 1.10 |
| 372 | Rett syndrome | Enrichment | MECP2 | 1.10 |
| 373 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | NGF | 1.10 |
| 374 | Multiple enchondromatosis, maffucci type | Enrichment | HIF1A | 1.10 |
| 375 | Gallbladder cancer | Enrichment | CTNNB1 | 1.10 |
| 376 | Pilomyxoid astrocytoma | Enrichment | NTRK2 | 1.10 |
| 377 | Colorectal cancer | Enrichment | CTNNB1, EP300, RET | 1.08 |
| 378 | Gastroesophageal reflux | Enrichment | CHAT | 1.05 |
| 379 | Erythrokeratodermia variabilis et progressiva 1 | Enrichment | GJA1 | 1.05 |
| 380 | Myopathy, tubular aggregate, 1 | Enrichment | CAV3 | 1.05 |
| 381 | Renal hypodysplasia/aplasia 1 | Enrichment | RET | 1.05 |
| 382 | Rett syndrome, congenital variant | Enrichment | MECP2 | 1.05 |
| 383 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.05 |
| 384 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | RYR2 | 1.05 |
| 385 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | RYR2 | 1.05 |
| 386 | Hypothyroidism | Enrichment | RET | 1.05 |
| 387 | Neuroblastoma | Enrichment | PHOX2B | 1.05 |
| 388 | Permanent neonatal diabetes mellitus | Enrichment | GCK | 1.05 |
| 389 | Hypoplastic left heart syndrome | Enrichment | GJA1 | 1.05 |
| 390 | Difference of sex development | Enrichment | AR | 1.05 |
| 391 | Gastric cancer | Enrichment | IL1B, IL1RN | 1.04 |
| 392 | West syndrome | Enrichment | GRIN1, NTRK2 | 1.03 |
| 393 | Rheumatoid arthritis | Enrichment | IL10 | 1.00 |
| 394 | Charge syndrome | Enrichment | EP300 | 1.00 |
| 395 | Inflammatory bowel disease 1 | Enrichment | IL6 | 1.00 |
| 396 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.00 |
| 397 | Primary hyperaldosteronism | Enrichment | NR3C1 | 1.00 |
| 398 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | SCN5A | 1.00 |
| 399 | Renal agenesis, bilateral | Enrichment | RET | 1.00 |
| 400 | Ciliary dyskinesia, primary, 3 | Enrichment | NFKB1 | 0.95 |
| 401 | Dravet syndrome | Enrichment | GABRA1 | 0.95 |
| 402 | Myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency | Enrichment | CHAT | 0.95 |
| 403 | Autosomal non-syndromic agammaglobulinemia | Enrichment | TCF3 | 0.95 |
| 404 | Ovarian cancer | Enrichment | AR, CTNNB1, RET | 0.94 |
| 405 | Body mass index quantitative trait locus 11 | Enrichment | BDNF, KCNH2 | 0.93 |
| 406 | Epilepsy, myoclonic juvenile | Enrichment | GABRA1 | 0.91 |
| 407 | Epilepsy, idiopathic generalized | Enrichment | GABRA1 | 0.91 |
| 408 | Myelodysplastic syndrome | Enrichment | GATA2 | 0.91 |
| 409 | Nanophthalmos | Enrichment | SOX2 | 0.91 |
| 410 | 46,xy complete gonadal dysgenesis | Enrichment | AR | 0.91 |
| 411 | Glycogen storage disease | Enrichment | G6PC1 | 0.91 |
| 412 | Diabetes mellitus | Enrichment | GCK | 0.91 |
| 413 | Mitochondrial myopathy | Enrichment | SLC25A4 | 0.91 |
| 414 | Specific learning disability | Enrichment | YWHAG | 0.91 |
| 415 | Ciliopathy | Enrichment | CC2D1A | 0.91 |
| 416 | Congenital nervous system abnormality | Enrichment | CREBBP, CTNNB1, MECP2 | 0.89 |
| 417 | Nervous system disease | Enrichment | CREBBP, CTNNB1, MECP2 | 0.89 |
| 418 | Epicanthus | Enrichment | ATP1A3 | 0.88 |
| 419 | Septooptic dysplasia | Enrichment | SOX2 | 0.88 |
| 420 | Renal hypodysplasia/aplasia 3 | Enrichment | RET | 0.88 |
| 421 | Lactic acidosis | Enrichment | CHAT | 0.88 |
| 422 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | RYR2 | 0.88 |
| 423 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | RYR2 | 0.88 |
| 424 | Myeloma, multiple | Enrichment | CREBBP, TCF3 | 0.85 |
| 425 | Pulmonary hypertension, primary, 1 | Enrichment | PAH | 0.85 |
| 426 | Pulmonary disease, chronic obstructive | Enrichment | CHRNB4 | 0.85 |
| 427 | Acute promyelocytic leukemia | Enrichment | PRKAR1A | 0.85 |
| 428 | Alzheimer's disease | Enrichment | TNF | 0.85 |
| 429 | Autosomal recessive non-syndromic intellectual disability | Enrichment | CC2D1A, GRIN1 | 0.83 |
| 430 | Medulloblastoma | Enrichment | CTNNB1 | 0.82 |
| 431 | Pheochromocytoma | Enrichment | RET | 0.82 |
| 432 | Heart disease | Enrichment | CREBBP | 0.82 |
| 433 | Congenital myasthenic syndrome | Enrichment | CHAT | 0.82 |
| 434 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | RYR2 | 0.82 |
| 435 | Polydactyly, postaxial, type a1 | Enrichment | EP300 | 0.79 |
| 436 | Wilms tumor 1 | Enrichment | REST | 0.79 |
| 437 | Corpus callosum, agenesis of | Enrichment | CREBBP | 0.79 |
| 438 | Myopia | Enrichment | SLC25A4 | 0.79 |
| 439 | Isolated corpus callosum agenesis | Enrichment | CREBBP | 0.79 |
| 440 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | CREBBP | 0.79 |
| 441 | Creatine phosphokinase, elevated serum | Enrichment | CAV3 | 0.76 |
| 442 | Hydrocephalus, congenital, 1 | Enrichment | ATP1A3 | 0.76 |
| 443 | Isolated elevated serum creatine phosphokinase levels | Enrichment | CAV3 | 0.76 |
| 444 | Cardiomyopathy, dilated, 1e | Enrichment | SCN5A | 0.74 |
| 445 | Polycystic liver disease | Enrichment | CTNNB1 | 0.74 |
| 446 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.74 |
| 447 | Beckwith-wiedemann syndrome | Enrichment | KCNQ1 | 0.72 |
| 448 | Human immunodeficiency virus type 1 | Enrichment | IL10 | 0.72 |
| 449 | Early infantile developmental and epileptic encephalopathy | Enrichment | GRIN1 | 0.72 |
| 450 | Arteriovenous malformations of the brain | Enrichment | IL6 | 0.70 |
| 451 | Diffuse large b-cell lymphoma | Enrichment | CREBBP | 0.70 |
| 452 | Inherited cancer-predisposing syndrome | Enrichment | PHOX2B, PRKAR1A, RET | 0.70 |
| 453 | Macs syndrome | Enrichment | SOX2 | 0.68 |
| 454 | Leukodystrophy | Enrichment | HSPD1 | 0.68 |
| 455 | Hepatoblastoma | Enrichment | CTNNB1 | 0.66 |
| 456 | Hereditary paraganglioma-pheochromocytoma syndromes | Enrichment | RET | 0.66 |
| 457 | Primary ciliary dyskinesia | Enrichment | CDCA7L, PRKAR1B | 0.65 |
| 458 | Attention deficit-hyperactivity disorder | Enrichment | MECP2 | 0.64 |
| 459 | Microphthalmia | Enrichment | SOX2 | 0.64 |
| 460 | Malaria | Enrichment | TNF | 0.62 |
| 461 | Congenital stationary night blindness | Enrichment | GNB3 | 0.62 |
| 462 | Ear malformation | Enrichment | KCNQ1 | 0.61 |
| 463 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | CAV3 | 0.61 |
| 464 | Autoinflammatory disease | Enrichment | IL1RN | 0.61 |
| 465 | Scoliosis | Enrichment | CREBBP | 0.61 |
| 466 | Developmental and epileptic encephalopathy 1 | Enrichment | GRIN1 | 0.59 |
| 467 | Tetralogy of fallot | Enrichment | RET | 0.58 |
| 468 | Auditory neuropathy | Enrichment | PLP1 | 0.58 |
| 469 | Bladder cancer | Enrichment | CTNNB1 | 0.54 |
| 470 | Prostate cancer | Enrichment | AR | 0.54 |
| 471 | Differentiated thyroid carcinoma | Enrichment | RET | 0.54 |
| 472 | Visceral heterotaxy 5 | Enrichment | CDCA7L | 0.51 |
| 473 | Cystic fibrosis | Enrichment | SLC9A3 | 0.50 |
| 474 | Peripheral nervous system disease | Enrichment | NGF | 0.50 |
| 475 | Neuropathy | Enrichment | NGF | 0.50 |
| 476 | Male infertility | Enrichment | AR | 0.48 |
| 477 | Cakut | Enrichment | GATA3 | 0.48 |
| 478 | Non-syndromic x-linked intellectual disability | Enrichment | MECP2 | 0.46 |
| 479 | Developmental and epileptic encephalopathy | Enrichment | SNAP25 | 0.46 |
| 480 | Fetal akinesia deformation sequence 1 | Enrichment | SCN5A | 0.45 |
| 481 | Cerebral palsy | Enrichment | CC2D1A | 0.43 |
| 482 | Leukemia, acute myeloid | Enrichment | GATA2 | 0.42 |
| 483 | Benign epilepsy with centrotemporal spikes | Enrichment | GRIN1 | 0.42 |
| 484 | Distal arthrogryposis | Enrichment | SCN5A | 0.41 |
| 485 | Hereditary spastic paraplegia | Enrichment | PLP1 | 0.41 |
| 486 | Centralopathic epilepsy | Enrichment | GRIN1 | 0.40 |
| 487 | Nephrotic syndrome | Enrichment | LMX1B | 0.40 |
| 488 | Hypertrophic cardiomyopathy | Enrichment | SLC25A4 | 0.40 |
| 489 | Optic atrophy plus syndrome | Enrichment | SNAP25 | 0.39 |
| 490 | Hereditary breast carcinoma | Enrichment | RET | 0.39 |
| 491 | Complex neurodevelopmental disorder | Enrichment | RORA, SPTBN1 | 0.37 |
| 492 | Sensorineural hearing loss | Enrichment | RET | 0.36 |
| 493 | Hypertelorism | Enrichment | RET | 0.34 |
| 494 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | REST | 0.34 |
| 495 | Familial isolated dilated cardiomyopathy | Enrichment | SCN5A | 0.33 |
| 496 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | AR | 0.32 |
| 497 | Schizophrenia | Enrichment | HTR2A | 0.30 |
| 498 | Rare genetic deafness | Enrichment | KCNQ1 | 0.22 |
| 499 | Dilated cardiomyopathy | Enrichment | SCN5A | 0.21 |
| 500 | Mitochondrial disease | Enrichment | SLC25A4 | 0.19 |
| 501 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | GJA1 | 0.19 |
| 502 | Hereditary retinal dystrophy | Enrichment | NEUROD1 | 0.01 |
| 503 | Fundus dystrophy | Enrichment | NEUROD1 | 0.01 |